Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kirk E Evoy, Lucas G Hill & Corey S Davis. (2021) Considering the Potential Benefits of Over-the-Counter Naloxone. Integrated Pharmacy Research and Practice 10, pages 13-21.
Read now
Read now
Claire A. Wood, Lauren Green, Anna La Manna, Sarah Phillips, Kimberly B. Werner, Rachel P. Winograd & Angie Stuckenschneider. (2021) Balancing need and risk, supply and demand: Developing a tool to prioritize naloxone distribution. Substance Abuse 42:4, pages 974-982.
Read now
Read now
Articles from other publishers (32)
G. Franklin Edwards III, Cassandra Mierisch, Allison Strauss, Brock Mutcheson, Keel Coleman, Kimberly Horn & Sarah Henrickson Parker. (2023) Evaluating rescuer performance in response to opioid overdose in a community setting: Evidence for medically appropriate process measures. Preventive Medicine Reports 32, pages 102145.
Crossref
Crossref
Hawraa Sameer Sajwani & Anna V Williams. (2022) A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs. Harm Reduction Journal 19:1.
Crossref
Crossref
Andrew Boslett & Elaine Hill. (2022) Mortality during resource booms and busts. Journal of Environmental Economics and Management 115, pages 102696.
Crossref
Crossref
Riya Ghose, Fiona Cowden, Abirami Veluchamy, Blair H Smith & Lesley A Colvin. (2022) Characteristics of non-fatal overdoses and associated risk factors in patients attending a specialist community-based substance misuse service. British Journal of Pain 16:4, pages 458-466.
Crossref
Crossref
Akeemat O. Tijani, Jivesh Garg, Dorcas Frempong, Gabrielle Verana, Jagroop Kaur, Ramesh Joga, Chetan D. Sabanis, Sandeep Kumar, Neeraj Kumar & Ashana Puri. (2022) Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges. Journal of Controlled Release 348, pages 970-1003.
Crossref
Crossref
Wasantha Jayawardene, Annie Pezalla, Cris Henderson & Michael Hecht. (2022) Development of opioid rapid response system: Protocol for a randomized controlled trial. Contemporary Clinical Trials 115, pages 106727.
Crossref
Crossref
Janie Simmons, Luther Elliott, Alex S Bennett, Leo Beletsky, Sonali Rajan, Brad Anders & Nicole Dastparvardeh. (2022) Evaluation of an Experimental Web-based Educational Module on Opioid-related Occupational Safety Among Police Officers: Protocol for a Randomized Pragmatic Trial to Minimize Barriers to Overdose Response. JMIR Research Protocols 11:2, pages e33451.
Crossref
Crossref
Nicholas T. Lappas & Courtney M. Lappas. 2022. Forensic Toxicology. Forensic Toxicology
45
71
.
Soroush Moallef, JinCheol Choi, M.-J. Milloy, Kora DeBeck, Thomas Kerr & Kanna Hayashi. (2021) A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting. Harm Reduction Journal 18:1.
Crossref
Crossref
Ashley Cid, Alec Patten, Kelly Grindrod & Michael A. Beazely. (2021) Frequently asked questions about naloxone: Part 2. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 154:6, pages 385-387.
Crossref
Crossref
Anne C Fernandez, Lewei A Lin, Angela R Bazzi, Jeff Boissoneault, Brian Borsari & Frederic Blow. (2021) Beliefs About Perioperative Opioid and Alcohol Use among Elective Surgical Patients Who Report Unhealthy Drinking: A Qualitative Study. Pain Medicine 22:10, pages 2384-2392.
Crossref
Crossref
A. Conway, H. Valerio, A. Peacock, L. Degenhardt, J. Hayllar, ME. Harrod, C. Henderson, P. Read, R. Gilliver, M. Christmass, A. Dunlop, M. Montebello, G. Whitton, D. Reid, T. Lam, M. Alavi, D. Silk, AD. Marshall, C. Treloar, GJ. Dore & J. Grebely. (2021) Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. International Journal of Drug Policy 96, pages 103421.
Crossref
Crossref
Ashana Puri, Dorcas Frempong, Dhruv Mishra & Prashant Dogra. (2021) Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid overdose. International Journal of Pharmaceutics 604, pages 120739.
Crossref
Crossref
Miriam Boeri & Aukje K. Lamonica. (2021) Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states. Journal of the American Association of Nurse Practitioners 33:4, pages 294-303.
Crossref
Crossref
G. Franklin EdwardsIIIIII, Cassandra Mierisch, Brock Mutcheson, Kimberly Horn & Sarah Henrickson Parker. (2020) A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs. Preventive Medicine Reports 20, pages 101232.
Crossref
Crossref
Theresa Winhusen, Christine Wilder, Michael S. Lyons, Jeff Theobald, Frankie Kropp & Daniel Lewis. (2020) Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Drug and Alcohol Dependence 216, pages 108265.
Crossref
Crossref
Chelsea A Wesner, Weiwei Zhang, Sandra Melstad, Elizabeth Ruen, Cassandra Deffenbaugh, Wei Gu & Joshua L Clayton. (2020) Assessing County-Level Vulnerability for Opioid Overdose and Rapid Spread of Human Immunodeficiency Virus and Hepatitis C Infection in South Dakota. The Journal of Infectious Diseases 222:Supplement_5, pages S312-S321.
Crossref
Crossref
Marc Fishman, Hoa T. Vo, Rachael Burgower, Michael Ruggiero, John Rotrosen, Josh Lee & Edward Nunes. (2020) Treatment Trajectories During and After a Medication Trial for Opioid Use Disorder: Moving from Research as Usual to Treatment as Usual. Journal of Addiction Medicine 14:4, pages 331-336.
Crossref
Crossref
Rajagopalan Vijayaraghavan. (2020) Autoinjector device for rapid administration of drugs and antidotes in emergency situations and in mass casualty management. Journal of International Medical Research 48:5, pages 030006052092601.
Crossref
Crossref
Gregory Carter & Penny Caudill. (2020) Integrating naloxone education into an undergraduate nursing course: Developing partnerships with a local department of health. Public Health Nursing 37:3, pages 439-445.
Crossref
Crossref
Philippe HaouziDaniel GuckMarissa McCannMolly SternickTakashi SonobeNicole Tubbs. (2020) Severe Hypoxemia Prevents Spontaneous and Naloxone-induced Breathing Recovery after Fentanyl Overdose in Awake and Sedated Rats. Anesthesiology 132:5, pages 1138-1150.
Crossref
Crossref
Sarah Bessen, Stephen A. Metcalf, Elizabeth C. Saunders, Sarah K. Moore, Andrea Meier, Bethany McLeman, Olivia Walsh & Lisa A. Marsch. (2019) Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. International Journal of Drug Policy 74, pages 144-151.
Crossref
Crossref
Michael Fendrich, Jessica Becker & Jennifer Hernandez-Meier. (2019) Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study. Addictive Behaviors Reports 10, pages 100212.
Crossref
Crossref
Nadia Peyravian, Emre Dikici, Sapna Deo, Michal Toborek & Sylvia Daunert. (2019) Opioid antagonists as potential therapeutics for ischemic stroke. Progress in Neurobiology 182, pages 101679.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
Hao-Jui Hsu, Yang Yang, Venkateswara Pavuluri, Ciby Abraham, Suresh Babu Naraharisetti, Muhammad Ashraf & Manar Al-Ghabeish. (2019) Effect of Formulation Variables on the Nasal Permeability and
Stability of Naloxone Intranasal Formulations. AAPS PharmSciTech 20:6.
Crossref
Crossref
Keith G. Heinzerling. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction
137
156
.
Geoffrey A. CapraroClaudia B. Rebola. (2018) The NaloxBox Program in Rhode Island: A Model for Community-Access Naloxone. American Journal of Public Health 108:12, pages 1649-1651.
Crossref
Crossref
Dennis P. Watson, Bradley Ray, Lisa Robison, Philip Huynh, Emily Sightes, La Shea Walker, Krista Brucker & Joan Duwve. (2018) Lay responder naloxone access and Good Samaritan law compliance: postcard survey results from 20 Indiana counties. Harm Reduction Journal 15:1.
Crossref
Crossref
Thomas Barré, Florence Vorspan, Maeva Fortias, Marc Veyrier, Pauline Cavagna, Julien Azuar, Louise Nicolas, François Naccache, Hélène Barreteau, Franck Bellivier & Vanessa Bloch. (2018) Pratique de l’ATU de cohorte de la naloxone intranasale (Nalscue®) : mise en place dans un CSAPA parisien. Therapies 73:6, pages 495-500.
Crossref
Crossref
Christopher Keane, James E. Egan & Mary Hawk. (2018) Effects of naloxone distribution to likely bystanders: Results of an agent-based model. International Journal of Drug Policy 55, pages 61-69.
Crossref
Crossref
Kate McKeage & Katherine A. Lyseng-Williamson. (2018) Naloxone nasal spray (Nyxoid®) in opioid overdose: a profile of its use in the EU. Drugs & Therapy Perspectives 34:4, pages 150-156.
Crossref
Crossref